Department of Neurology, E-Da Hospital/School of Medicine, I-Shou University, Kaohsiung, Taiwan.
Department of Anesthesiology, Chi Mei Medical Center, Tainan, Taiwan.
J Anesth. 2024 Apr;38(2):155-166. doi: 10.1007/s00540-023-03219-y. Epub 2023 Jul 5.
The prevalence of postoperative emergence delirium in paediatric patients (pedED) following desflurane anaesthesia is considerably high at 50-80%. Although several pharmacological prophylactic strategies have been introduced to reduce the risk of pedED, conclusive evidence about the superiority of these individual regimens is lacking. The aim of the current study was to assess the potential prophylactic effect and safety of individual pharmacotherapies in the prevention of pedED following desflurane anaesthesia.
This frequentist model network meta-analysis (NMA) of randomized controlled trials (RCTs) included peer-reviewed RCTs of either placebo-controlled or active-controlled design in paediatric patients under desflurane anaesthesia.
Seven studies comprising 573 participants were included. Overall, the ketamine + propofol administration [odds ratio (OR) = 0.05, 95% confidence intervals (95%CIs) 0.01-0.33], dexmedetomidine alone (OR = 0.13, 95%CIs 0.05-0.31), and propofol administration (OR = 0.30, 95%CIs 0.10-0.91) were associated with a significantly lower incidence of pedED than the placebo/control groups. In addition, only gabapentin and dexmedetomidine were associated with a significantly higher improvement in the severity of emergence delirium than the placebo/control groups. Finally, the ketamine + propofol administration was associated with the lowest incidence of pedED, whereas gabapentin was associated with the lowest severity of pedED among all of the pharmacologic interventions studied.
The current NMA showed that ketamine + propofol administration was associated with the lowest incidence of pedED among all of the pharmacologic interventions studied. Future large-scale trials to more fully elucidate the comparative benefits of different combination regimens are warranted.
PROSPERO CRD42021285200.
在接受七氟醚麻醉的小儿患者(pedED)中,术后苏醒谵妄的发生率相当高,为 50-80%。尽管已经提出了几种药理学预防策略来降低 pedED 的风险,但这些单独方案的优势尚无确凿证据。本研究旨在评估个别药物治疗预防七氟醚麻醉后 pedED 的潜在效果和安全性。
这是一项针对接受七氟醚麻醉的小儿患者的随机对照试验(RCT)的有频率派模型网络荟萃分析(NMA)。
纳入了 7 项研究,共 573 名参与者。总体而言,氯胺酮+丙泊酚给药[比值比(OR)=0.05,95%置信区间(95%CI)0.01-0.33]、右美托咪定单独给药(OR=0.13,95%CI 0.05-0.31)和丙泊酚给药(OR=0.30,95%CI 0.10-0.91)与安慰剂/对照组相比,发生 pedED 的发生率显著降低。此外,只有加巴喷丁和右美托咪定与安慰剂/对照组相比,苏醒谵妄严重程度的改善更为显著。最后,氯胺酮+丙泊酚给药与所有研究药物干预中最低的 pedED 发生率相关,而加巴喷丁与所有研究药物干预中最低的 pedED 严重程度相关。
本 NMA 表明,在所有研究的药物干预中,氯胺酮+丙泊酚给药与最低的 pedED 发生率相关。需要进行更大规模的试验以更充分地阐明不同联合方案的比较优势。
PROSPERO CRD42021285200。